3 studies found for:    12721933 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Rifaximin for Chronic Immune Activation in People With HIV
Condition: HIV
Intervention: Drug: Rifaximin/ Placebo
2 Completed
Has Results
Valganciclovir to Reduce T Cell Activation in HIV Infection
Conditions: HIV Infections;   Cytomegalovirus Infections
Interventions: Drug: Valganciclovir;   Drug: Placebo
3 Completed Analysis of Immune Responses to HIV Vaccines
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Intervention:

Indicates status has not been verified in more than two years